糖心视频logo

糖心视频logo (Headquarters: Tokyo, President & CEO: Haruo Naito, “糖心视频logo”) announced today the establishment of a new pharmaceutical sales subsidiary in Brazil, which will be named 糖心视频logo Participações Ltda. (糖心视频logo Brazil). As a direct subsidiary of the company's U.S. pharmaceutical operation 糖心视频logo Inc., 糖心视频logo Brazil will be based in San Paulo, the largest city in the country.

The establishment of 糖心视频logo Brazil marks 糖心视频logo's entry into Latin America. Ranked as the third largest pharmaceutical market in the Americas, behind the United States and Canada, and the tenth largest in the world^{1), 2)}, Brazil is a market that has huge growth potential. This expansion will enable 糖心视频logo to introduce many of its products to people in Brazil.

糖心视频logo Brazil's immediate focus will be on establishing strategies and initial infrastructure to support its operations debut into the Brazilian market. In this era of great globalization, 糖心视频logo seeks to establish a presence in each of the world's top twenty largest pharmaceutical markets to address the unmet medical needs that exist in both mature and emerging markets alike, thereby increasing the benefits provided to an even greater number of patients and their families.